• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

COVID-19 Vulnerability Index Identifies Urban Populations at High Risk

Share:

March 31, 2020

Data science and visualization company RS21 has created a data analytics website to help address the challenges of COVID-19. The Urban Health Vulnerability Index (UHVI) identifies urban populations at high risk for COVID-19, including older adults and people with serious medical conditions. The public health app is intended to support mid- to long-term planning in the face of health, economic and social disruptions.

The UHVI quickly and clearly communicates information in a map-type interface, making it easy to use by decision-makers, analysts and citizens. Datasets come from the Centers for Disease Control, the US Census, COVID-19 cases, healthcare facilities and other disparate data sources.

Urban Health Vulnerability Index Coverage Areas

The UHVI originally included metro areas in New Mexico where the company is headquartered. It now shows data for the following cities:

Albuquerque, NM

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Aurora, CO

Atlanta, GA

Chicago, IL

Colorado Springs, CO

Denver, CO

Las Cruces, NM

New Orleans, LA

New York, NY

Phoenix, AZ

Santa Fe, NM

Washington, D.C.

UHVI Methodology:

The UHVI measures the overall chronic disease burden of a census tract. Chronic conditions used calculate the UHVI include: asthma, COPD, diabetes, cancer, smoking, coronary heart disease, hypertension, stroke, kidney disease, and old age (>= 65 years). For each state we rank census tracts by the prevalence of each chronic condition. We then sum these condition ranks for each census tract to get an aggregate score. This aggregate score is then used to rank each tract within the state producing the final UHVI.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AmWell IPO and Google Deal – Five Key Takeaways to KnowAmWell IPO and Google Deal – Five Key Takeaways to Know
  • ApolloMD Partners with Cedar to Implement Optimized Online Patient Billing ExperienceApolloMD Partners with Cedar to Implement Optimized Online Patient Billing Experience
  • AI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidateAI drug development partnership between GlaxoSmithKline, Exscientia yields first drug candidate
  • Atai Life Sciences Takes on Opioid Crisis By Acquiring Kures to Develop Novel Therapeutics for Opioid AbuseAtai Life Sciences Takes on Opioid Crisis By Acquiring Kures to Develop Novel Therapeutics for Opioid Abuse
  • Germany’s Stada buys six of GSK’s consumer brands, eyes further dealsGermany’s Stada buys six of GSK’s consumer brands, eyes further deals
  • Amazon, Google, Apple to drive life sciences market to $1.5T by 2022, report saysAmazon, Google, Apple to drive life sciences market to $1.5T by 2022, report says
  • New rules to expedite regulator nod for clinical trialsNew rules to expedite regulator nod for clinical trials
  • Xerostomia Therapeutics Market To Witness Significant GrowthXerostomia Therapeutics Market To Witness Significant Growth

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications